share_log

PharmaCyte Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ayrton Capital LLC(9.99%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.99%), etc.

PharmaCyte Biotech | SC 13G:超過5%持股股東披露文件-Ayrton Capital LLC(9.99%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.99%)等

美股SEC公告 ·  2023/05/19 17:19
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息